Wearable Competitors

Pink Sheets . USA . 
Stock . Wearable Health Solutions
WHSI Stock  USD 0.0001  0.00  0.00%   
Wearable Health Solutions competes with GlucoTrack, Sharps Technology, Utah Medical, Innovative Eyewear, and Microbot Medical; as well as few others. The company conducts business under Healthcare sector and is part of Medical Instruments & Supplies industry. Analyzing Wearable Health competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Wearable Health to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Wearable Health Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Wearable Health competition on your existing holdings.
  
Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Wearable Health's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.000.00010.00
Details
Intrinsic
Valuation
LowRealHigh
0.000.0000840.00
Details

Wearable Health Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Wearable Health and its competitors represents the degree of relationship between the price movements of corresponding pink sheets. A correlation of about +1.0 implies that the price of Wearable and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Wearable Health Solutions does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
TEVNF
+ 0.86
GCTK
MHUA
+ 0.84
GCTK
STSS
+ 0.77
CEOS
MHUA
+ 0.66
TEVNF
MHUA
+ 0.62
STSS
STSS
+ 0.55
GCTK
  
High negative correlations   
LUCY
- 0.6
CEOS
MHUA
- 0.58
MBOT
MBOT
- 0.46
STSS
LUCY
- 0.45
STSS
MBOT
- 0.35
GCTK
MBOT
- 0.28
TEVNF

Risk-Adjusted Indicators

There is a big difference between Wearable Pink Sheet performing well and Wearable Health Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Wearable Health's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
CEOS  7.71  0.02  0.02  0.12  7.75 
(10.05)
 16.96 
(13.16)
 81.48 
GCTK  6.11 (2.61) 0.00 (0.85) 0.00 
 0.00 
 10.40 
(13.89)
 90.86 
STSS  4.81 (0.68) 0.00 (1.84) 0.00 
 0.00 
 9.29 
(10.90)
 31.55 
WHSI  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
TEVNF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
UTMD  0.70 (0.15) 0.00 (0.06) 0.00 
 0.00 
 1.12 
(1.82)
 7.07 
LUCY  6.22  0.66  0.11  0.56  6.16 
(7.21)
 20.90 
(10.45)
 47.29 
MBOT  2.12  0.12  0.02  0.48  2.22 
(3.08)
 5.38 
(4.60)
 15.87 
MHUA  5.67 (0.62) 0.00 (0.36) 0.00 
 0.00 
 14.89 
(13.11)
 45.51 
All Fundamental Data

Wearable Health Competitive Analysis

The better you understand Wearable Health competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Wearable Health's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Wearable Health's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
WHSI CEOS GCTK STSS UTMD LUCY MBOT MHUA
 0.00 
 0.0001 
Wearable
 3.57 
 0.03 
CeCors
 4.00 
 0.24 
GlucoTrack
 10.90 
 3.35 
Sharps
 0.21 
 65.39 
Utah
 3.75 
 6.92 
Innovative
 3.09 
 1.00 
Microbot
 1.89 
 0.52 
Meihua
Market Volatility
(90 Days Market Risk)
Very steady
Out of control
Out of control
Unstable
Very steady
Very risky
Unstable
Out of control
Market Performance
(90 Days Performance)
Very Weak
Weak
Very Weak
Very Weak
Very Weak
OK
OK
Very Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
Average
Very High
Very High
Very High
Very Low
Low
Low
Low
Current Valuation
(Equity Enterprise Value)
Over Valued
Over Valued
Fairly Valued
Under Valued
Fairly Valued
Over Valued
Under Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Strong Buy
Strong Sell
Buy
Buy
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Hold
Strong Sell
Strong Sell
Strong Sell
Current Ratio
0.12 X
0.33 X
4.52 X
2.64 X
13.44 X
0.34 X
5.60 X
5.45 X
Net Asset
339.06 K
2.26 M
4.91 M
11.79 M
135.46 M
6.22 M
8.33 M
171.92 M
Profit Margin
N/A
N/A
N/A
N/A
0.35 %
N/A
N/A
0.1 %
EBITDA
(12.96 M)
(3.72 M)
(7.09 M)
(8.98 M)
24.75 M
(6.58 M)
(10.63 M)
15.77 M
Operating Margin
(10.12) %
N/A
N/A
N/A
0.38 %
(6.95) %
N/A
0.13 %
Current Valuation
9.9 M
87.7 K
3.9 M
6.62 M
133.15 M
12.77 M
12.69 M
7.06 M
Price To Book
N/A
N/A
21.40 X
1.04 X
1.78 X
1.49 X
4.45 X
0.09 X
Retained Earnings
(14.2 M)
(33.91 M)
(109.85 M)
(25.15 M)
138.34 M
(16.97 M)
(79.5 M)
94.64 M
Current Asset
521 K
114 K
N/A
N/A
32.87 M
7.51 M
15.21 M
N/A
Five Year Return
N/A
N/A
N/A
N/A
1.20 %
N/A
N/A
N/A
Beta
7.58
0.11
0.16
1.19
0.08
2.79
1.63
0.53
Number Of Employees
11
6
6
57
169
11
21
617
Shares Outstanding
1.53 B
N/A
8.21 M
1.8 M
3.39 M
2.44 M
16.93 M
26.09 M
Cash Flow From Operations
(3.11 M)
(6.88 M)
(6.56 M)
(8.51 M)
22.28 M
(5.77 M)
(8.53 M)
2.28 M
Annual Yield
N/A
0.04 %
N/A
N/A
0.02 %
N/A
N/A
N/A
Total Debt
1.7 M
956.88 K
196 K
3.85 M
295 K
659.94 K
231 K
7.33 M
Return On Equity
N/A
-7.26
-5.41
-1.03
0.12
-0.87
-1.34
0.0642
Z Score
N/A
-24.3
N/A
N/A
N/A
N/A
N/A
N/A
Return On Asset
-5.3
-1.8
-1.57
-0.52
0.0818
-0.53
-0.65
0.042
Book Value Per Share
(0) X
(0.02) X
0.77 X
11.43 X
36.10 X
4.51 X
0.38 X
5.73 X
Number Of Shares Shorted
N/A
N/A
257.74 K
60.04 K
55.26 K
98.08 K
586.82 K
401.93 K
Current Liabilities
1.29 M
343 K
N/A
N/A
4.07 M
5.78 M
9.83 M
N/A
Total Asset
339.06 K
2.26 M
4.91 M
11.79 M
135.46 M
6.22 M
8.33 M
171.92 M
Target Price
0.2
N/A
N/A
352.0
N/A
14.0
7.0
N/A
Debt To Equity
N/A
N/A
0.06 %
0.56 %
0 %
N/A
0.07 %
0.04 %
Short Ratio
N/A
N/A
6.03 X
0.38 X
2.09 X
0.17 X
2.65 X
0.40 X
Last Dividend Paid
N/A
N/A
N/A
N/A
1.2
N/A
N/A
N/A
Shares Owned By Institutions
N/A
N/A
0.95 %
4.02 %
73.64 %
3.51 %
7.46 %
8.70 %
Market Capitalization
9.8 M
14.15 K
2.04 M
5.81 M
221.78 M
16.3 M
16.93 M
14.35 M
Price To Earning
1.13 X
(0.05) X
N/A
N/A
31.38 X
N/A
(3.42) X
13.75 X
Price To Sales
6.39 X
N/A
N/A
N/A
5.03 X
10.44 X
N/A
0.15 X
Net Income
(13.05 M)
(9.3 M)
(7.1 M)
(9.84 M)
16.64 M
(6.66 M)
(10.74 M)
11.59 M
Earnings Per Share
0.01 X
(0.41) X
(2.91) X
(8.24) X
4.28 X
(10.10) X
(0.79) X
0.37 X
Shares Owned By Insiders
66.89 %
N/A
34.97 %
3.70 %
6.89 %
51.50 %
1.42 %
56.47 %
Revenue
1.05 M
N/A
N/A
N/A
50.22 M
1.15 M
N/A
97.1 M
Working Capital
(772 K)
(229 K)
3.36 M
1.15 M
101.56 M
4.99 M
4.13 M
107.16 M
Cash And Equivalents
70.5 K
57.42 K
3.85 M
7.81 M
69.51 M
34.88 K
9.29 M
34.17 M
Cash Per Share
N/A
N/A
0.25 X
0.85 X
19.17 X
N/A
1.31 X
1.43 X
Gross Profit
477.48 K
N/A
(20 K)
N/A
32.2 M
148.25 K
N/A
37.97 M
Day Typical Price
1.0E-4
0.0268
0.24
3.55
65.21
6.87
1.01
0.53
Accumulation Distribution
N/A
0.16
0.12
0.18
0.0134
0.0457
0.0481
0.0714
Market Facilitation Index
N/A
0.0047
0.03
0.7
0.88
0.32
0.05
0.04
Daily Balance Of Power
0.0
(0.21)
(0.33)
(0.59)
0.1591
0.7813
0.6
(0.25)
Period Momentum Indicator
N/A
(0)
(0.01)
(0.41)
0.14
0.25
0.03
(0.01)
Rate Of Daily Change
1.0
0.96
0.96
0.89
1.0
1.04
1.03
0.98
Day Median Price
1.0E-4
0.0267
0.25
3.65
65.12
6.84
1.02
0.54
Price Action Indicator
N/A
(0.0001)
(0.01)
(0.50)
0.34
0.21
N/A
(0.03)
Coefficient Of Variation
N/A
4815.53
(510.74)
(1,140)
(2,376)
1076.37
1760.04
(1,792)
Mean Deviation
N/A
7.71
6.11
4.81
0.6986
6.22
2.12
5.67
Jensen Alpha
N/A
0.021
(2.61)
(0.68)
(0.15)
0.6585
0.1211
(0.62)
Total Risk Alpha
N/A
(1.63)
(4.06)
(1.71)
(0.22)
(0.52)
(0.29)
(1.70)
Sortino Ratio
N/A
0.0157
N/A
N/A
N/A
0.108
0.0153
N/A
Downside Variance
N/A
75.87
N/A
N/A
N/A
43.69
8.75
N/A
Standard Deviation
N/A
12.56
11.73
7.16
1.07
9.02
2.98
8.21
Kurtosis
N/A
11.96
25.87
3.56
7.3
2.8
2.19
2.31
Potential Upside
N/A
16.96
10.4
9.29
1.12
20.9
5.38
14.89
Treynor Ratio
N/A
0.1247
(0.85)
(1.84)
(0.06)
0.5586
0.4751
(0.36)
Maximum Drawdown
N/A
81.48
90.86
31.55
7.07
47.29
15.87
45.51
Variance
N/A
157.64
137.49
51.31
1.15
81.33
8.9
67.44
Market Risk Adjusted Performance
N/A
0.1347
(0.84)
(1.83)
(0.05)
0.5686
0.4851
(0.35)
Risk Adjusted Performance
N/A
0.0253
(0.14)
(0.06)
(0.03)
0.0801
0.0508
(0.03)
Skewness
N/A
2.8
(4.36)
(0.83)
1.69
1.41
0.8912
0.1649
Semi Deviation
N/A
7.75
N/A
N/A
N/A
6.16
2.22
N/A
Information Ratio
N/A
0.0109
(0.21)
(0.11)
(0.16)
0.0791
0.0152
(0.07)
Value At Risk
N/A
(13.16)
(13.89)
(10.90)
(1.82)
(10.45)
(4.60)
(13.11)
Expected Short fall
N/A
(10.05)
N/A
N/A
N/A
(7.21)
(3.08)
N/A
Downside Deviation
N/A
8.71
N/A
N/A
N/A
6.61
2.96
N/A
Semi Variance
N/A
60.04
N/A
N/A
N/A
37.99
4.95
N/A

Wearable Health Competition Performance Charts

Five steps to successful analysis of Wearable Health Competition

Wearable Health's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Wearable Health Solutions in relation to its competition. Wearable Health's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Wearable Health in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Wearable Health's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Wearable Health Solutions, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Wearable Health position

In addition to having Wearable Health in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Electronic Equipment Thematic Idea Now

Electronic Equipment
Electronic Equipment Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Electronic Equipment theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Electronic Equipment Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Wearable Pink Sheet

Wearable Health financial ratios help investors to determine whether Wearable Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Wearable with respect to the benefits of owning Wearable Health security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY